Influenza Program, Thailand Ministry of Public Health - U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
Influenza Other Respir Viruses. 2015 Mar;9(2):85-93. doi: 10.1111/irv.12302. Epub 2015 Jan 5.
Since 2009, Thailand has recommended influenza vaccine for children aged 6 months through 2 years, but no estimates of influenza vaccine coverage or effectiveness are available for this target group.
During August 2011-May 2013, high-risk and healthy children aged ≤36 months were enrolled in a 2-year prospective cohort study. Parents were contacted weekly about acute respiratory illness (ARI) in their child. Ill children had combined nasal and throat swabs tested for influenza viruses by real-time reverse transcription-polymerase chain reaction. Influenza vaccination status was verified with vaccination cards. The Cox proportional hazards approach was used to estimate hazard ratios. Vaccine effectiveness (VE) was estimated as 100% x (1-hazard ratio).
During 2011-2013, 968 children were enrolled (median age, 10·3 months); 948 (97·9%) had a vaccination record and were included. Of these, 394 (41·6%) had ≥1 medical conditions. Vaccination coverage for the 2011-2012 and 2012-2013 seasons was 29·3% (93/317) and 30·0% (197/656), respectively. In 2011-2012, there were 213 ARI episodes, of which 10 (4·6%) were influenza positive (2·3 per 1000 vaccinated and 3·8 per 1000 unvaccinated child-weeks). The VE was 55% (95% confidence interval [CI], -72, 88). In 2012-2013, there were 846 ARIs, of which 52 (6·2%) were influenza positive (1·8 per 1000 vaccinated and 4·5 per 1000 unvaccinated child-weeks). The VE was 64% (CI, 13%, 85%).
Influenza vaccination coverage among young children in Thailand was low, although vaccination was moderately effective. Continued efforts are needed to increase influenza vaccination coverage and evaluate VE among young children in Thailand.
自 2009 年以来,泰国已推荐为 6 个月至 2 岁的儿童接种流感疫苗,但针对这一目标人群,尚无流感疫苗接种率或有效性的估计。
2011 年 8 月至 2013 年 5 月期间,纳入了患有≤36 个月高危和健康儿童的 2 年前瞻性队列研究。每周通过急性呼吸道疾病(ARI)向儿童的父母询问有关其子女的情况。患有 ARI 的儿童通过实时逆转录-聚合酶链反应联合鼻和咽拭子检测流感病毒。通过疫苗接种卡核实流感疫苗接种情况。使用 Cox 比例风险法估计风险比。疫苗有效性(VE)估计为 100%×(1-风险比)。
2011 年至 2013 年期间,共纳入 968 名儿童(中位年龄为 10.3 个月);其中 948 名(97.9%)有疫苗接种记录,并纳入分析。其中,394 名(41.6%)有≥1 种医疗状况。2011-2012 年和 2012-2013 年两个季节的疫苗接种率分别为 29.3%(93/317)和 30.0%(197/656)。2011-2012 年,共发生 213 次 ARI 发作,其中 10 次(4.6%)为流感阳性(每 1000 名接种疫苗儿童中有 2.3 例,每 1000 名未接种疫苗儿童中有 3.8 例发病)。VE 为 55%(95%CI,-72,88)。2012-2013 年,共发生 846 次 ARI,其中 52 次(6.2%)为流感阳性(每 1000 名接种疫苗儿童中有 1.8 例,每 1000 名未接种疫苗儿童中有 4.5 例发病)。VE 为 64%(CI,13%,85%)。
泰国幼儿的流感疫苗接种率较低,但疫苗接种具有一定的有效性。需要继续努力提高泰国幼儿的流感疫苗接种率,并评估幼儿的疫苗有效性。